EXROF(EXROF)
EXROF
No analyst ratings available
No analyst price targets available for EXROF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $63M | $168M |
| Low | $63M | $168M |
| High | $63M | $168M |
| EBITDA Avg | $-13M | $-34M |
| Low | $-13M | $-34M |
| High | $-13M | $-34M |
| EBIT Avg | $-13M | $-34M |
| Low | $-13M | $-34M |
| High | $-13M | $-34M |
| Net Income Avg | $-26M | $-46M |
| Low | $-26M | $-46M |
| High | $-26M | $-46M |
| EPS Avg | $-0.06 | $-0.10 |
| Low | $-0.06 | $-0.10 |
| High | $-0.06 | $-0.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $39M | $50M | $40M | $41M | $43M | $45M |
| Low | $39M | $50M | $40M | $41M | $43M | $45M |
| High | $39M | $50M | $40M | $41M | $43M | $45M |
| EBITDA Avg | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| Low | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| High | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| EBIT Avg | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| Low | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| High | $-8M | $-10M | $-8M | $-8M | $-9M | $-9M |
| Net Income Avg | $-14M | $-6M | — | — | — | — |
| Low | $-14M | $-6M | — | — | — | — |
| High | $-14M | $-6M | — | — | — | — |
| EPS Avg | $-0.02 | $-0.01 | — | — | — | — |
| Low | $-0.02 | $-0.01 | — | — | — | — |
| High | $-0.02 | $-0.01 | — | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |